vs
CORCEPT THERAPEUTICS INC（CORT）与PROCORE TECHNOLOGIES, INC.（PCOR）财务数据对比。点击上方公司名可切换其他公司
PROCORE TECHNOLOGIES, INC.的季度营收约是CORCEPT THERAPEUTICS INC的1.8倍（$359.3M vs $202.1M），CORCEPT THERAPEUTICS INC净利率更高（12.0% vs -2.5%，领先14.5%），PROCORE TECHNOLOGIES, INC.同比增速更快（15.7% vs 11.1%），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 12.4%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
Procore Technologies是2002年成立的美国建筑管理软件即服务（SaaS）企业，总部位于加利福尼亚州卡平特里亚。公司打造的全球平台可连接建筑行业从业者，支持搭建简化工作流，统一展现建筑项目信息，覆盖任务追踪、项目流程管理、日程排期等核心功能。
CORT vs PCOR — 直观对比
营收规模更大
PCOR
是对方的1.8倍
$202.1M
营收增速更快
PCOR
高出4.5%
11.1%
净利率更高
CORT
高出14.5%
-2.5%
两年增速更快
CORT
近两年复合增速
12.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $359.3M |
| 净利润 | $24.3M | $-9.1M |
| 毛利率 | 98.7% | 80.1% |
| 营业利润率 | 2.2% | 15.5% |
| 净利率 | 12.0% | -2.5% |
| 营收同比 | 11.1% | 15.7% |
| 净利润同比 | -21.0% | 72.4% |
| 每股收益（稀释后） | $0.20 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTPCOR
| Q1 26 | — | $359.3M | ||
| Q4 25 | $202.1M | $349.1M | ||
| Q3 25 | $207.6M | $338.9M | ||
| Q2 25 | $194.4M | $323.9M | ||
| Q1 25 | $157.2M | $310.6M | ||
| Q4 24 | $181.9M | $302.0M | ||
| Q3 24 | $182.5M | $295.9M | ||
| Q2 24 | $163.8M | $284.3M |
净利润CORTPCOR
| Q1 26 | — | $-9.1M | ||
| Q4 25 | $24.3M | $-37.6M | ||
| Q3 25 | $19.7M | $-9.1M | ||
| Q2 25 | $35.1M | $-21.1M | ||
| Q1 25 | $20.5M | $-33.0M | ||
| Q4 24 | $30.7M | $-62.3M | ||
| Q3 24 | $47.2M | $-26.4M | ||
| Q2 24 | $35.5M | $-6.3M |
毛利率CORTPCOR
| Q1 26 | — | 80.1% | ||
| Q4 25 | 98.7% | 80.1% | ||
| Q3 25 | 97.8% | 79.7% | ||
| Q2 25 | 98.2% | 79.1% | ||
| Q1 25 | 98.5% | 79.1% | ||
| Q4 24 | 98.4% | 81.2% | ||
| Q3 24 | 98.4% | 81.4% | ||
| Q2 24 | 98.5% | 83.1% |
营业利润率CORTPCOR
| Q1 26 | — | 15.5% | ||
| Q4 25 | 2.2% | -12.3% | ||
| Q3 25 | 4.9% | -4.4% | ||
| Q2 25 | 13.7% | -9.3% | ||
| Q1 25 | 2.2% | -11.7% | ||
| Q4 24 | 13.9% | -21.9% | ||
| Q3 24 | 25.5% | -12.3% | ||
| Q2 24 | 21.7% | -5.2% |
净利率CORTPCOR
| Q1 26 | — | -2.5% | ||
| Q4 25 | 12.0% | -10.8% | ||
| Q3 25 | 9.5% | -2.7% | ||
| Q2 25 | 18.1% | -6.5% | ||
| Q1 25 | 13.1% | -10.6% | ||
| Q4 24 | 16.9% | -20.6% | ||
| Q3 24 | 25.9% | -8.9% | ||
| Q2 24 | 21.7% | -2.2% |
每股收益（稀释后）CORTPCOR
| Q1 26 | — | $-0.06 | ||
| Q4 25 | $0.20 | $-0.25 | ||
| Q3 25 | $0.16 | $-0.06 | ||
| Q2 25 | $0.29 | $-0.14 | ||
| Q1 25 | $0.17 | $-0.22 | ||
| Q4 24 | $0.25 | $-0.42 | ||
| Q3 24 | $0.41 | $-0.18 | ||
| Q2 24 | $0.32 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $386.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $1.2B |
| 总资产 | $836.7M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTPCOR
| Q1 26 | — | $386.0M | ||
| Q4 25 | $372.2M | $768.5M | ||
| Q3 25 | $421.7M | $684.0M | ||
| Q2 25 | $342.2M | $620.9M | ||
| Q1 25 | $322.8M | $566.7M | ||
| Q4 24 | $383.3M | $775.4M | ||
| Q3 24 | $380.3M | $756.9M | ||
| Q2 24 | $473.2M | $735.4M |
股东权益CORTPCOR
| Q1 26 | — | $1.2B | ||
| Q4 25 | $647.8M | $1.3B | ||
| Q3 25 | $631.9M | $1.2B | ||
| Q2 25 | $635.8M | $1.2B | ||
| Q1 25 | $683.3M | $1.2B | ||
| Q4 24 | $679.6M | $1.3B | ||
| Q3 24 | $638.8M | $1.3B | ||
| Q2 24 | $596.2M | $1.3B |
总资产CORTPCOR
| Q1 26 | — | $2.1B | ||
| Q4 25 | $836.7M | $2.2B | ||
| Q3 25 | $823.6M | $2.1B | ||
| Q2 25 | $801.7M | $2.0B | ||
| Q1 25 | $846.5M | $1.9B | ||
| Q4 24 | $840.6M | $2.1B | ||
| Q3 24 | $784.3M | $2.0B | ||
| Q2 24 | $714.6M | $2.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $76.8M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | — |
| 自由现金流率自由现金流/营收 | 19.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.58× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CORTPCOR
| Q1 26 | — | $76.8M | ||
| Q4 25 | $38.4M | $114.9M | ||
| Q3 25 | $54.5M | $88.5M | ||
| Q2 25 | $43.9M | $30.8M | ||
| Q1 25 | $5.1M | $66.0M | ||
| Q4 24 | $59.3M | $29.1M | ||
| Q3 24 | $73.8M | $39.3M | ||
| Q2 24 | $41.2M | $58.7M |
自由现金流CORTPCOR
| Q1 26 | — | — | ||
| Q4 25 | $38.4M | $109.2M | ||
| Q3 25 | — | $83.1M | ||
| Q2 25 | $43.9M | $27.9M | ||
| Q1 25 | $5.0M | $62.0M | ||
| Q4 24 | $59.2M | $17.4M | ||
| Q3 24 | $72.2M | $35.7M | ||
| Q2 24 | $40.8M | $56.8M |
自由现金流率CORTPCOR
| Q1 26 | — | — | ||
| Q4 25 | 19.0% | 31.3% | ||
| Q3 25 | — | 24.5% | ||
| Q2 25 | 22.6% | 8.6% | ||
| Q1 25 | 3.2% | 20.0% | ||
| Q4 24 | 32.5% | 5.8% | ||
| Q3 24 | 39.5% | 12.1% | ||
| Q2 24 | 24.9% | 20.0% |
资本支出强度CORTPCOR
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 1.6% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.1% | 1.3% | ||
| Q4 24 | 0.1% | 3.9% | ||
| Q3 24 | 0.9% | 1.2% | ||
| Q2 24 | 0.3% | 0.7% |
现金转化率CORTPCOR
| Q1 26 | — | — | ||
| Q4 25 | 1.58× | — | ||
| Q3 25 | 2.77× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 1.93× | — | ||
| Q3 24 | 1.56× | — | ||
| Q2 24 | 1.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
